About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

Fuso Pharmaceutical Industries,Ltd.(4538) Summary

4538
TSE Prime
Fuso Pharmaceutical Industries,Ltd.
2,092
JPY
-86
(-3.95%)
Apr 9, 3:30 pm JST
14.38
USD
Apr 9, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
6.8
PBR
0.46
Yield
3.92%
Margin Trading Ratio
22.59
Stock Price
Apr 9, 2025
Opening Apr 9, 9:00 am
2,166 JPY 14.85 USD
Previous Close Apr 8
2,178 JPY 14.76 USD
High Apr 9, 9:00 am
2,166 JPY 14.85 USD
Low Apr 9, 1:23 pm
2,080 JPY 14.34 USD
Volume
24,100
Trading Value
0.05B JPY 0.35M USD
VWAP
2108.58 JPY 14.51 USD
Minimum Trading Value
209,200 JPY 1,438 USD
Market Cap
0.02T JPY 0.14B USD
Number of Trades
121
Liquidity & Number of Trades
As of Apr 9, 2025
Liquidity
Mid
1-Year Average
85
1-Year High Nov 11, 2024
1,027
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 4, 2025 1,600 39,600 24.75
Mar 28, 2025 7,200 37,100 5.15
Mar 21, 2025 403,400 39,800 0.10
Mar 14, 2025 379,800 44,500 0.12
Mar 7, 2025 283,700 47,800 0.17
Company Profile
Fuso Pharmaceutical Industries, Ltd. is a leading manufacturer of artificial kidney dialysis solutions and holds a high market share in blood-related pharmaceuticals. The company also produces medical devices and generic drugs.
Sector
Pharmaceuticals
Fuso Pharmaceutical Industries, Ltd. primarily engages in the manufacture and sale of medical pharmaceuticals and medical equipment. In the field of medical pharmaceuticals, the company focuses on the production and distribution of injectable solutions, particularly infusion fluids, and artificial kidney dialysis agents. Additionally, the company undertakes contract manufacturing of pharmaceuticals and develops generic drugs. Beyond its pharmaceutical operations, Fuso has established a presence in the real estate sector through property leasing. By encompassing a wide range of activities from manufacturing to sales, primarily in the medical field, Fuso has built a diversified revenue structure.